Staplin, N., Mayne, M., Abat, S., Abd Rahman, R., Abdul Cader, R., Abdul Hafidz, M., . . . Judge, P. (2023). Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: Secondary analyses of the EMPA-KIDNEY trial. Elsevier.
Citazione stile Chigago Style (17a edizione)Staplin, N., et al. Impact of Primary Kidney Disease on the Effects of Empagliflozin in Patients with Chronic Kidney Disease: Secondary Analyses of the EMPA-KIDNEY Trial. Elsevier, 2023.
Citatione MLA (9a ed.)Staplin, N., et al. Impact of Primary Kidney Disease on the Effects of Empagliflozin in Patients with Chronic Kidney Disease: Secondary Analyses of the EMPA-KIDNEY Trial. Elsevier, 2023.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.